New Book Challenges Longevity Science by Exposing Fraudulent Age Records and Flawed Blue Zones Data

Saul Justin Newman’s new book, 'Morbid: Debunking Modern Longevity Science,' argues that foundational aging research is compromised by unreliable age records and fraudulent pension claims. The book highlights cases like Sogen Kato, a Japanese man found dead for decades while still receiving a pension, suggesting that up to 82% of recorded Japanese centenarians may have been deceased or missing. Newman contends that this data corruption invalidates popular 'Blue Zones' lifestyle advice, noting that promoted habits like high vegetable consumption or religious community involvement do not match the actual behaviors of long-lived populations like Okinawans. While experts debate the exact scale of the error, the book questions the validity of anti-aging treatments and supplements sold without proven efficacy.
Key points
- Saul Justin Newman’s book 'Morbid' questions the reliability of age records used in longevity research, citing a 2010 incident in Tokyo where a man named Sogen Kato was found dead for at least 30 years while still receiving a pension.
- Newman claims that a Japanese audit revealed 234,354 people on family registers whose whereabouts could not be confirmed, representing over 82% of the recorded centenarian population, though researchers argue the actual number of missing individuals was only 600.
- The book critiques 'Blue Zones' guides, noting that Okinawans, often cited for longevity, have the highest Kentucky Fried Chicken consumption in Japan, the worst BMI, and are 93.4% atheist, contradicting advice to eat vegetables and join religious communities.
- Newman argues that anti-aging treatments, such as resveratrol supplements, were marketed before evidence of human efficacy was established, with GlaxoSmithKline closing its Sirtris operation in 2013 after the promise of the compound ran ahead of the science.
- Experts like Dr. Marcus Ranney emphasize 'geroscience' over 'anti-aging,' focusing on extending healthspan rather than lifespan, and warn that longevity is not about defeating death but delaying disease and maintaining independence.
Background
This story follows broader discussions on healthy aging myths, including recent advice from physicians that older adults still need seven to nine hours of sleep and that strength training preserves muscle mass. The debate also intersects with the commercialization of longevity, where expensive therapies and supplements are often marketed without proven benefits, contrasting with evidence-based lifestyle habits like regular exercise and social connection.
How outlets are covering it
The New York Post highlights Saul Justin Newman’s critical view that aging science is built on flawed data, citing specific cases of pension fraud and contradictory lifestyle habits in Blue Zones. In contrast, Outlook India features Dr. Marcus Ranney, who acknowledges the hype around longevity but focuses on the scientific validity of geroscience, arguing that while reversing aging is delusional, extending healthspan through basic habits is achievable. NewsRadio 560 KPQ offers a more general public health perspective, debunking common myths about sleep and diet without addressing the specific data integrity issues raised by Newman. The outlets differ in emphasis: the Post focuses on the scandal of fraudulent records, Outlook India on the distinction between science and marketing, and KPQ on practical daily habits.
Why it matters
The reliability of age records is fundamental to understanding human lifespan and developing effective anti-aging strategies. If a significant portion of centenarian data is fraudulent or inaccurate, as Newman suggests, the lessons drawn from 'Blue Zones' and other longevity studies may be invalid. This impacts public health advice, the development of medical interventions, and the marketing of supplements, potentially leading to misguided lifestyle choices and wasted resources. Clarifying the difference between geroscience and anti-aging marketing is crucial for setting realistic expectations for healthy aging.
What to watch
Researchers and scientists are expected to continue debating the validity of Newman’s claims regarding the scale of missing centenarians in Japan. The longevity industry may face increased scrutiny regarding the evidence behind supplements and therapies. Public discourse will likely shift further toward evidence-based geroscience, focusing on healthspan and disease prevention rather than extreme lifespan extensions. Future audits of age records in other countries, such as Greece, may provide more clarity on the global impact of pension fraud on aging research.
- Living past 100: This is the real secret — and what scientists have gotten wrong New York Post
- Longevity myths experts wish people would stop repeating qz.com
- Six Healthy-Aging Myths Doctors Say You Can Stop Believing Today NewsRadio 560 KPQ
- Longevity: Busting Biggest Myths Outlook India
- Can we really live forever? The tech, science and ethics behind chasing immortality Stuff
Want the full story? Read the original reporting
Read on New York Post